Navigation Links
NYU Steinhardt researchers to study why male millennials risk HIV transmission

The number of new HIV infections in the United States had remained steady in recent years, but rates among urban millennial gay, bisexual, and other young men who have sex with men (YMSM) have steadily increased in the past decade.

New York University researchers, led by Perry Halkitis, a professor at the Steinhardt School of Culture, Education, and Human Development, the Global Institute of Public Health, and NYU Langone Medical Center, will study this population in order to better understand the reasons for this increase under a five-year, $3.1 million grant from the National Institute on Drug Abuse, part of the National Institutes of Health.

The research is a continuation of a study of young men that began in 2009 under the name Project 18 (P18).

"The goal of this project is to understand why a new generation of YMSM place themselves at risk for HIV transmission," explains Halkitis, who is also associate dean for academic affairs at NYU's Global Institute of Public Health. "We aim to understand why some men exhibit risky behaviors as they emerge into adulthood while others do not."

The project's other researchers include three faculty in NYU Steinhardt's Public Health programFarzana Kapadia, the primary co-investigator, Danielle Ompad, and Rafael Perez Figueroaas well as Richard Greene, an assistant professor at NYU Langone Medical Center.

YMSM include not only gay men, but also those who are bisexual and heterosexual men but who have had sex with other men but do not identify as gay or bisexual.

Under the grant, the research team will continue its cohort study of nearly 600 racially, ethnically, and socioeconomically diverse YMSM that began when the subjects were in their late teens and who are now in their early 20s. The study will also expand this cohort and recruit some 300 additional men who are also now in their early 20s.

The study will consider several factors that may explain the rise in incidence rates, ranging from the behavioral to the structural, including the social and sexual networks of YMSM, the role of homophobia and discrimination in society, and the presence of other sexually transmitted infectionsas well as substance use and mental health burdens.

In addition, the researchers will consider the factors that explain both resilience and riskwhy some acquire HIV while others do not and how does the development of sexual risk coincide with other health conditions. The goal, they explain, is to move away from a program of research focused solely on deficit models and to also consider how new biomedical technologies such as PrEP (pre exposure prophylaxis) affect HIV health in a new generation of men.

Armed with greater insights into the factors that lead to growing rates of HIV among this population, the researchers will seek to create ways to address it, in part, as informed by the effective strategies some young men are utilizing.

"Working with community and municipal partners, we will draw from what we have learned to develop strategies for HIV prevention and intervention that are relevant to this current and developing generation who did not live through the devastation of the AIDS epidemic in the 1980s," says Halkitis.


Contact: James Devitt
New York University

Related medicine news :

1. More alcohol and traffic laws mean fewer traffic deaths, NYU Steinhardt study concludes
2. Researchers generate immunity against tumor vessel protein
3. Researchers at LSTM part of the international team to sequence the tsetse genome
4. Oxygen diminishes the hearts ability to regenerate, researchers discover
5. Finnish team of researchers finds a mutation in a tumor of the jaw
6. Depressed? Researchers identify new anti-depressant mechanisms, therapeutic approaches
7. Life stressors trigger neurological disorders, researchers find
8. Penn researchers find link between sleep and immune function in fruit flies
9. Penn Medicine researchers uncover hints of a novel mechanism behind general anesthetic action
10. CU researchers discover target for treating dengue fever
11. BUSM researchers find anti-seizure drug may reduce alcohol consumption
Post Your Comments:
(Date:6/25/2016)... ... June 25, 2016 , ... ... non-athletes recover from injury. Recently, he has implemented orthobiologic procedures as a method ... —Johnson is one of the first doctors to perform the treatment. Orthobiologics are ...
(Date:6/24/2016)... ... 2016 , ... Those who have experienced traumatic events may suffer from a ... such as drug or alcohol abuse, as a coping mechanism. To avoid this pain ... following a traumatic event. , Trauma sufferers tend to feel a range of emotions, ...
(Date:6/24/2016)... ... June 24, 2016 , ... Global law firm Greenberg Traurig, P.A. announced that ... chosen by their peers for this recognition are considered among the top 2 percent ... special honors as members of this year’s Legal Elite Hall of Fame: Miami ...
(Date:6/24/2016)... ... June 24, 2016 , ... People across the U.S. are sharpening their pencils ... an essay contest in which patients and their families pay tribute to a genetic ... 2016 National Society of Genetic Counselors (NSGC) Annual Education Conference (AEC) this September. ...
(Date:6/24/2016)... Maryland (PRWEB) , ... June 24, 2016 , ... ... Angels is actively feeding the Frederick area economy by obtaining investment capital for ... over the past 2½ years that have already resulted in more than a ...
Breaking Medicine News(10 mins):
(Date:6/23/2016)... and BOGOTA, Colombia , June 23, 2016  Astellas today announced the establishment of Astellas ... Brasil as the company,s second affiliate in Latin America . ... ... of Astellas Farma Colombia ... ...
(Date:6/23/2016)... The vast majority of dialysis patients currently ... are usually 3 times a week, with treatment times ... time, equipment preparation and wait time.  This regimen can ... patients who are elderly and frail.  Many elderly dialysis ... centers for some duration of time. Residents ...
(Date:6/23/2016)... June 23, 2016 The Biotechnology ... continues to present great opportunities to investors. assesses ... Intrexon Corp. (NYSE: XON ), Vertex Pharmaceuticals ... (NASDAQ: ARNA ), and Regeneron Pharmaceuticals Inc. ... stocks and receive your complimentary trade alerts at: ...
Breaking Medicine Technology: